These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 19760959)

  • 1. Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients.
    Lin TJ; Liao LY; Chou JM; Liu SO; Wang CK
    Hepatogastroenterology; 2009; 56(93):1146-51. PubMed ID: 19760959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C.
    Tsochatzis E; Papatheodoridis GV; Koliaraki V; Hadziyannis E; Kafiri G; Manesis EK; Mamalaki A; Archimandritis AJ
    J Viral Hepat; 2010 Nov; 17(11):800-6. PubMed ID: 20002304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C.
    Aoki CA; Rossaro L; Ramsamooj R; Brandhagen D; Burritt MF; Bowlus CL
    J Clin Gastroenterol; 2005 Jan; 39(1):71-4. PubMed ID: 15599216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma prohepcidin levels in patients with chronic viral hepatitis: relationship with liver fibrosis.
    Olmez OF; Gurel S; Yilmaz Y
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):461-5. PubMed ID: 19940783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin.
    Malyszko J; Malyszko JS; Kozminski P; Mysliwiec M
    Ren Fail; 2009; 31(10):876-83. PubMed ID: 20030521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
    Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
    Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
    Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
    Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M.
    Beirão I; Almeida S; Swinkels D; Costa PM; Moreira L; Fonseca I; Freitas C; Cabrita A; Porto G
    Blood Cells Mol Dis; 2008; 41(2):175-8. PubMed ID: 18544472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C.
    Hofer H; Osterreicher C; Jessner W; Penz M; Steindl-Munda P; Wrba F; Ferenci P
    J Hepatol; 2004 Jun; 40(6):1018-22. PubMed ID: 15158344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does hepcidin affect erythropoiesis in hemodialysis patients?
    Eleftheriadis T; Kartsios C; Liakopoulos V; Antoniadi G; Ditsa M; Papadopoulos C; Anifandis G; Skirta A; Markala D; Stefanidis I
    Acta Haematol; 2006; 116(4):238-44. PubMed ID: 17119323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C.
    Yadav D; Hertan HI; Schweitzer P; Norkus EP; Pitchumoni CS
    Am J Gastroenterol; 2002 Oct; 97(10):2634-9. PubMed ID: 12385452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy.
    Malyszko J; Malyszko JS; Mysliwiec M
    Kidney Blood Press Res; 2009; 32(4):235-8. PubMed ID: 19713706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
    Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
    J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum prohepcidin and other iron metabolism parameters in healthy adults].
    Zekanowska E; Boinska J; Kwapisz J; Kedziora-Kornatowska K; Porzych K; Ratajczak M
    Przegl Lek; 2011; 68(2):82-6. PubMed ID: 21751515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin is down-regulated in alcohol loading.
    Ohtake T; Saito H; Hosoki Y; Inoue M; Miyoshi S; Suzuki Y; Fujimoto Y; Kohgo Y
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S2-8. PubMed ID: 17331161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
    Costa E; Pereira BJ; Rocha-Pereira P; Rocha S; Reis F; Castro E; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
    Am J Nephrol; 2008; 28(4):677-83. PubMed ID: 18354252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of and correspondence among different hepcidin forms in blood and urine and their relationships to iron status in healthy, male Guatemalan volunteers observed over 9 weeks.
    Schuemann K; Solomons NW; Laarakkers CM; Romero-Abal ME; Kroll S; Weiss G; Swinkels DW
    Ann Nutr Metab; 2011; 58(2):158-66. PubMed ID: 21654163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
    Fujita N; Sugimoto R; Ma N; Tanaka H; Iwasa M; Kobayashi Y; Kawanishi S; Watanabe S; Kaito M; Takei Y
    J Viral Hepat; 2008 Jul; 15(7):498-507. PubMed ID: 18331251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of erythropoietin therapy on serum prohepcidin levels in dialysis patients.
    Arabul M; Gullulu M; Yilmaz Y; Eren MA; Baran B; Gul CB; Kocamaz G; Dilek K
    Med Sci Monit; 2009 Nov; 15(11):CR583-7. PubMed ID: 19865058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.
    Kato A; Tsuji T; Luo J; Sakao Y; Yasuda H; Hishida A
    Am J Nephrol; 2008; 28(1):115-21. PubMed ID: 17943020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.